| Literature DB >> 24324391 |
Mohammad Shokrzadeh1, Aroona Chabra, Farshad Naghshvar, Amirhossein Ahmadi.
Abstract
Possible genoprotective effect of Citrullus colocynthis (L.) (CCT) fruits extract against cyclophosphamide- (CP-)induced DNA damage in mice bone marrow cells was evaluated using micronucleus assay, as an index of induced chromosomal damage. Mice were preadministered with different doses of CCT via intraperitoneal injection for 7 consecutive days followed by injection with CP (70 mg/kg b.w.) 1 hr after the last injection of CCT. After 24 hr, mice were scarified to evaluate the frequency of micronucleated polychromatic erythrocytes (MnPCEs). In addition, the number of polychromatic erythrocytes (PCEs) among 1000 normochromatic erythrocytes (NCEs) per animal was recorded to evaluate bone marrow. Pretreatment with CCT significantly reduced the number of MnPCEs induced by CP in bone marrow cells (P < 0.0001). At 200 mg/kg, CCT had a maximum chemoprotective effect and reduced the number of MnPCEs by 6.37-fold and completely normalized the mitotic activity. CCT also led to marked proliferation and hypercellularity of immature myeloid elements after mice were treated with CP and mitigated the bone marrow suppression. Our study revealed that CCT has an antigenotoxic effect against CP-induced oxidative DNA damage in mice. Therefore, it could be used concomitantly as a supplement to protect people undergoing chemotherapy.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24324391 PMCID: PMC3842040 DOI: 10.1155/2013/980480
Source DB: PubMed Journal: ScientificWorldJournal ISSN: 1537-744X
Figure 1Inhibition effect of CCT fruits extract on the DPPH free radical at 517 nm.
Frequency of MnPCE and mitotic activity (% PCE) in bone marrow cells of mice treated with CCT fruits extract and/or CP.
| Group | Treatment | % MnPCEa | % PCEa |
|---|---|---|---|
| 1 | Control | 0.54 ± 0.08 | 51.32 ± 6.21 |
| 2 | CP | 6.14 ± 0.36b | 32.48 ± 4.15b |
| 3 | CCT 10 mg/kg + CP | 5.94 ± 0.72d | 31.28 ± 7.85d |
| 4 | CCT 50 mg/kg + CP | 3.62 ± 0.81f | 40.62 ± 5.14f |
| 5 | CCT 100 mg/kg + CP | 1.04 ± 0.27c,e | 48.89 ± 6.78c,e |
| 6 | CCT 200 mg/kg + CP | 0.92 ± 0.06c,e | 50.32 ± 8.01c,e |
| 7 | CCT 200 mg/kg | 0.47 ± 0.14e | 51.79 ± 5.46e |
CCT: Citrullus colocynthis; CP: cyclophosphamide; MnPCE: micronucleated polychromatic erythrocyte.
aValues are the mean ± standard deviation for each group of 5 mice. b P < 0.0001 compared to the control; c P < 0.0001 compared with the CP treated group; f P < 0.001 compared with the CP treated group. dNo significant difference compared to the CP group. eNo significant difference compared to the control group.
The data were analyzed with one-way ANOVA and Tukey's HSD test.
Levels of MDA, GSH, GSSG, and GSH/GSSG ratio in bone marrow of mice after treatment with CCT (200 mg/kg) and/or CP (70 mg/kg).
| Groups (mg/kg) | MDA ( | GSH ( | GSSG ( | GSH/GSSG ratio |
|---|---|---|---|---|
| Control | 0.74 ± 0.17 | 13.64 ± 4.36 | 3.38 ± 0.43 | 4.03 ± 1.07 |
| CP | 3.07 ± 0.42b | 3.81 ± 1.47b | 13.38 ± 3.76b | 0.28 ± 0.05b |
| CCT | 0.71 ± 0.32c | 14.69 ± 5.16c | 2.97 ± 0.35c | 4.94 ± 1.72c |
| CCT + CP | 1.32 ± 0.24d | 12.37 ± 3.84e | 6.14 ± 3.84d | 2.01 ± 0.63d |
CCT: Citrullus colocynthis; CP: cyclophosphamide; MDA: lipid peroxidation; GSH: reduced glutathione; GSSG: oxidized glutathione.
aValues are the mean ± standard deviation for each group of 5 mice. b P < 0.0001 compared to the control. cNo significant difference compared to the control group; d P < 0.001 compared with the CP treated group;e P < 0.0001 compared with the CP treated group.
The data were analyzed with one-way ANOVA and Tukey's HSD test.
Figure 2Myeloid hypoplasia in femur 24 hours after CP administration 70 mg/kg; (a) compared with myeloid hyperplasia induced by administration of CCT fruits extract at 100 mg/kg; (b) & 200 mg/kg; (c) for 7 consecutive days before CP treatment. CP-induced myelosuppressive effects (a) and CCT led to marked proliferation and hypercellularity of immature myeloid elements after mice were treated with CP and mitigated the bone marrow suppression ((b) and (c)). Note the relative increase in the proportion of myeloid to erythroid precursors after CCT administration (hematoxylin and eosin-stained paraffin sections).